ACHC

ACHC

USD

Acadia Healthcare Company Inc. Common Stock

$22.150-0.030 (-0.135%)

即時價格

Healthcare
Medical Care Facilities
美國

價格圖表

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$22.180

最高

$22.540

最低

$21.710

交易量

0.17M

公司基本面

市值

2.0B

行業

Medical Care Facilities

國家

United States

交易統計

平均交易量

2.25M

交易所

NMS

貨幣

USD

52週範圍

最低 $20.36當前 $22.150最高 $82.41

AI分析報告

最後更新: 2025年4月28日
由AI生成數據來源: Yahoo Finance, Bloomberg, SEC

ACHC: Acadia Healthcare Company Inc. Common Stock - Analyzing Recent Moves & What Might Come Next

Stock Symbol: ACHC Generate Date: 2025-04-28 17:22:58

Alright, let's break down what's been going on with Acadia Healthcare (ACHC) and what the data we have might suggest. Think of this as looking at the puzzle pieces to see the potential picture.

What's Been Happening? (News & Price Check)

First off, the news front has been a bit of a mixed bag lately, at least regarding analyst opinions. Back in late March, Mizuho kept a "Neutral" rating on the stock but actually lowered their price target from $48 down to $37. That's not exactly a ringing endorsement, especially the lower target part. Fast forward to early April, and Guggenheim steps in with a "Buy" rating, setting their price target at $36. So, you've got one firm saying "Neutral" with a $37 target and another saying "Buy" with a $36 target. Both targets are well above where the stock is trading now, but the ratings themselves offer different takes. The overall vibe from these two pieces is cautiously optimistic from the analyst perspective, but the lowered target from Mizuho adds a note of caution.

Now, let's look at the stock price itself over the last three months or so. The chart tells a pretty clear story of a significant drop. Back in late January, shares were trading up around the $44-$45 mark. Then came a sharp decline, particularly noticeable around late February, dropping into the low $30s. The slide didn't stop there; the price has continued to drift lower, hitting the low $20s recently. The current price is sitting right around $21.89. This is a dramatic fall from those earlier levels and puts the stock near its 52-week low of $20.36. So, while analysts have targets much higher, the actual price action has been strongly negative for quite some time.

Looking Ahead (Predictions & Analyst Views)

We've got some AI predictions for the very near term. The model suggests today's price change might be flat (0.00%), but it forecasts a small bounce over the next couple of days: a 2.00% increase tomorrow and another 3.15% the day after. This suggests the AI sees a potential short-term uptick from the current depressed levels.

Beyond the immediate AI prediction, the broader analyst picture (as summarized in the recommendation data) is quite interesting. It mentions a strong buy rating from 13 analysts with a much higher average price target of $46.38. This implies a potential upside of over 100% from the current price if those analysts are right over the longer term. The AI prediction model also shows high confidence and projects an upward trend with a potential target price of $1.02 (this specific number seems low compared to the percentage predictions and analyst targets, likely a different scale or short-term view, but the direction is upward).

Putting It All Together (Outlook & Ideas)

So, what does this mix of information tell us? The recent price trend for ACHC has been undeniably tough, showing a significant decline over the past few months, bringing it down near its yearly low. However, the analyst community, on average, seems to believe the stock is worth significantly more than its current trading price, with some initiating or maintaining positive ratings and high price targets. The AI model also points to a potential small bounce in the very near term from these low levels.

Given the sharp drop and the disconnect between the current price and analyst targets, alongside the AI predicting a short-term positive move, the situation might lean towards a potential opportunity for those comfortable with risk, if they believe the stock is undervalued at these levels and the analyst/AI outlook will eventually influence the price.

  • Potential Entry Consideration: If someone were considering getting in, the current price area, hovering just above the 52-week low and aligning with the AI's predicted starting point for a bounce, could be a point of interest. The recommendation data also highlighted entry points around $22.16 - $22.28, which is right where the stock is now. This area looks interesting because it's near a significant low point, potentially offering a better entry price if a turnaround were to occur.
  • Potential Exit/Stop-Loss Consideration: Managing risk is key. The recommendation data suggests a potential stop-loss level around $19.92. This is just below the 52-week low, acting as a point to potentially cut losses if the price continues to fall significantly. For taking profits, the recommendation data gives a very near-term target of $22.58, which aligns with the AI's predicted bounce range. Longer-term profit targets would be much higher, closer to the analyst averages, but those come with more uncertainty and a longer time horizon.

It's important to remember there are also fundamental concerns noted, like high debt and lower growth/ROE compared to some benchmarks, plus a technical MACD "death cross" signal which is typically seen as bearish. These factors could weigh on the stock.

A Bit About the Company

Just for context, Acadia Healthcare is in the Medical Care Facilities part of the Healthcare sector. They focus on providing behavioral healthcare services. So, news or trends related to mental health, addiction treatment, or healthcare policy could definitely impact their business and stock price. They have a good number of employees (over 19,000), indicating a substantial operation.

Important Note

This analysis is based only on the data provided and is intended for informational purposes. It's like getting one opinion; it's not financial advice. Stock markets are unpredictable, and prices can go down as well as up. Before making any investment decisions, you should always do your own thorough research, consider your own financial situation and risk tolerance, and ideally, consult with a qualified financial advisor.

相關新聞

Analyst Upgrades

Guggenheim Initiates Coverage On Acadia Healthcare Co with Buy Rating, Announces Price Target of $36

Guggenheim analyst Jason Cassorla initiates coverage on Acadia Healthcare Co with a Buy rating and announces Price Target of $36.

查看更多
Guggenheim Initiates Coverage On Acadia Healthcare Co with Buy Rating, Announces Price Target of $36
Analyst Upgrades

Mizuho Maintains Neutral on Acadia Healthcare Co, Lowers Price Target to $37

Mizuho analyst Ann Hynes maintains Acadia Healthcare Co with a Neutral and lowers the price target from $48 to $37.

查看更多
Mizuho Maintains Neutral on Acadia Healthcare Co, Lowers Price Target to $37

AI預測Beta

AI推薦

看漲

更新於: 2025年4月28日 上午01:34

看跌中立看漲

65.3% 信心度

風險與交易

風險級別3/5
中等風險
適合
價值
交易指南

入場點

$22.16

獲利了結

$22.58

止損

$19.92

關鍵因素

PDI 7.4 在 MDI 7.0 上方,ADX 15.9,表明看漲趨勢
當前價格非常接近支撐位 ($22.12),表明強勁的買入機會
交易量是平均值 (26,775) 的 6.8 倍,表明極強的買入壓力
MACD 0.0308 在信號線 0.0342 下方,表示看跌交叉

保持更新

設定價格提醒,獲取AI分析更新和即時市場新聞。